Such high-throughput analyses have recently identified new prostate cancer biomarkers, including, for example, HEPSIN, EZH2 and α-methyl-Co-racemase (AMACR) (Dhanasekaran et al, 2001; Jiang et al, 2001; Luo et al, 2001; Magee et al, 2001; Stamey et al, 2001; Varambally et al, 2002; Rhodes et al, 2003; Parekh et al, 2007). This evidence concerns the gene AMACR and Familial prostate cancer.